The Emotra clinical multicentre study, EUDOR-A, which was started during the spring of 2014, has been finalized. The study clearly demonstrates a lower number of suicides in comparison with previous studies, particularly and statistically significantly in the hyporeactive group. During the meeting between participants in the study in Rome the last two days, 29th to 30th of March, the results were carefully analysed. A consensus was reached and it was agreed to endorse the plans to launch EDOR® in Europé.

 

170331 – Emotra – PM – Consensus meeting supports EDOR launch plans